Epidermal growth factor receptor inhibitors: Difference between revisions

From Libre Pathology
Jump to navigation Jump to search
Newer edit →
Michael (talk | contribs)
49,316 edits
create
 
Michael (talk | contribs)
49,316 edits
m w
Line 7: Line 7:
==Use==
==Use==
*[[Lung adenocarcinoma]].
*[[Lung adenocarcinoma]].
*[[Colorectal adenocarcinoma]].


==References==
==References==

Revision as of 03:29, 28 November 2011

Epidermal growth factor receptor inhibitors, abbreviated EGFR inhibitors, is a class of drugs that blocks the EGF receptor.

Drugs

  • Gefitinib (Iressa).[1]
  • Erlotinib (Tarceva)).[1]

Use

References

  1. ↑ 1.0 1.1 Sun Y, Ren Y, Fang Z, et al. (October 2010). "Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases". J. Clin. Oncol. 28 (30): 4616–20. doi:10.1200/JCO.2010.29.6038. PMID 20855837.
Retrieved from "https://librepathology.org/w/index.php?title=Epidermal_growth_factor_receptor_inhibitors&oldid=10052"